BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//www.nepatientsafety.org//NONSGML kigkonsult.se iCalcreator 2.30.1
 0//
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:4e00da06-dd55-44f9-bfb3-5cccb5d13d4f
X-WR-CALDESC:Adverse drug events (ADEs)—including medication errors\, overd
 oses\, allergic reactions\, and side effects from drugs taken as prescribe
 d—are a major but often underrecognized threat to public health.  Recent a
 nalyses suggest that ADEs are the 3rd leading cause of death in the United
  States. UNMC’s Christopher Shaffer\, PharmD\, PhD\, MS will be our speake
 r. He will also share about his work in Pharmacogenomics at the Munroe-Mey
 er Institute and the launch of a similar program at Nebraska Childrens and
  Nebraska Medicine.
X-WR-RELCALID:13209f0b0506f7bbf70486c3ac9f68c8
X-WR-TIMEZONE:America/Chicago
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:STANDARD
TZNAME:CST
DTSTART:20251102T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
RDATE:20261101T020000
RDATE:20271107T020000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:CDT
DTSTART:20260308T020000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
RDATE:20270314T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:5ad15f06-7580-4ee0-bd6d-7bedf3b19399
DTSTAMP:20260514T094011Z
DESCRIPTION:Adverse drug events (ADEs)—including medication errors\, overdo
 ses\, allergic reactions\, and side effects from drugs taken as prescribed
 —are a major but often underrecognized threat to public health.  Recent an
 alyses suggest that ADEs are the 3rd leading cause of death in the United 
 States. UNMC’s Christopher Shaffer\, PharmD\, PhD\, MS will be our speaker
 . He will also share about his work in Pharmacogenomics at the Munroe-Meye
 r Institute and the launch of a similar program at Nebraska Childrens and 
 Nebraska Medicine.
DTSTART;TZID=America/Chicago:20260709T120000
DTEND;TZID=America/Chicago:20260709T130000
LOCATION:https://unmc.zoom.us/j/99184986215?pwd=ItcIIabPZ6P9O7FJJrfwDmedaR9
 k6f.1
SUMMARY:Adverse Drug Events & Pharmacogenomics
END:VEVENT
END:VCALENDAR
